New Zealand markets closed

Spero Therapeutics, Inc. (SPRO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.7800+0.0010 (+0.13%)
At close: 04:00PM EDT
0.7800 0.00 (0.00%)
After hours: 05:46PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
13,025
18,256
9,330
18,147
3,966
Operating expenses
Research development
63,093
64,526
67,003
65,775
33,885
Selling general and administrative
48,707
41,701
21,440
15,588
12,887
Total operating expenses
111,800
106,227
88,443
81,363
46,772
Operating income or loss
-98,775
-87,971
-79,113
-63,216
-42,806
Interest expense
4,428
1,940
-
-
-
Total other income/expenses net
-279
-191
432
963
1,144
Income before tax
-103,162
-89,756
-78,280
-60,925
-41,662
Income from continuing operations
-103,162
-89,756
-78,280
-60,925
-41,662
Net income
-103,162
-89,756
-78,280
-60,925
-41,662
Net income available to common shareholders
-103,162
-89,756
-78,280
-60,925
-41,662
Basic EPS
-
-2.91
-3.52
-3.35
-2.60
Diluted EPS
-
-2.91
-3.52
-3.35
-2.60
Basic average shares
-
30,896
22,386
18,161
16,002
Diluted average shares
-
30,896
22,386
18,161
16,002
EBITDA
-
-87,170
-78,352
-62,466
-42,397